A detailed history of Sabal Trust CO transactions in Baxter International Inc stock. As of the latest transaction made, Sabal Trust CO holds 7,640 shares of BAX stock, worth $251,126. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,640
Previous 7,640 -0.0%
Holding current value
$251,126
Previous $255,000 13.73%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$37.32 - $49.29 $171,373 - $226,339
-4,592 Reduced 37.54%
7,640 $288,000
Q2 2023

Jul 20, 2023

BUY
$39.98 - $47.68 $1,679 - $2,002
42 Added 0.34%
12,232 $557,000
Q1 2023

Apr 26, 2023

SELL
$37.58 - $52.57 $1,879 - $2,628
-50 Reduced 0.41%
12,190 $494,000
Q4 2022

Jan 31, 2023

BUY
$49.7 - $57.71 $1,739 - $2,019
35 Added 0.29%
12,240 $623,000
Q3 2022

Oct 18, 2022

BUY
$53.86 - $66.8 $807 - $1,002
15 Added 0.12%
12,205 $657,000
Q1 2021

Apr 19, 2021

SELL
$76.38 - $86.03 $31,697 - $35,702
-415 Reduced 3.29%
12,190 $1.03 Million
Q4 2020

Jan 20, 2021

SELL
$75.39 - $82.36 $226,170 - $247,080
-3,000 Reduced 19.22%
12,605 $1.01 Million
Q1 2020

Apr 14, 2020

BUY
$71.57 - $93.3 $11,809 - $15,394
165 Added 1.07%
15,605 $1.27 Million
Q2 2019

Jul 17, 2019

SELL
$73.44 - $82.41 $8,445 - $9,477
-115 Reduced 0.74%
15,440 $1.27 Million
Q1 2019

Apr 12, 2019

SELL
$64.48 - $81.31 $7,286 - $9,188
-113 Reduced 0.72%
15,555 $1.26 Million
Q2 2018

Jul 16, 2018

SELL
$63.43 - $75.41 $20,043 - $23,829
-316 Reduced 1.98%
15,668 $1.16 Million
Q1 2018

Apr 16, 2018

SELL
$62.56 - $72.26 $11,511 - $13,295
-184 Reduced 1.14%
15,984 $1.04 Million
Q4 2017

Feb 07, 2018

SELL
$61.45 - $66.05 $4,608 - $4,953
-75 Reduced 0.46%
16,168 $1.05 Million
Q3 2017

Oct 17, 2017

BUY
$59.5 - $64.61 $966,458 - $1.05 Million
16,243
16,243 $1.02 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Sabal Trust CO Portfolio

Follow Sabal Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.